Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2001;38:914-921
doi: 10.1161/hy1001.095773
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Van Bortel, L. M.A.B.
Right arrow Articles by Safar, M. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Van Bortel, L. M.A.B.
Right arrow Articles by Safar, M. E.
Related Collections
Right arrow Remodeling
Right arrow Cardiovascular Pharmacology
Right arrow Risk Factors
Right arrow Peripheral vascular disease
Right arrow Mechanism of atherosclerosis/growth factors

(Hypertension. 2001;38:914.)
© 2001 American Heart Association, Inc.


Fourth Workshop on Structure and Function of Large Arteries

Pulse Pressure, Arterial Stiffness, and Drug Treatment of Hypertension

Luc M.A.B. Van Bortel; Harry A.J. Struijker-Boudier; Michel E. Safar

From the Department of Clinical Pharmacology and Pharmacotherapy, Heymans Institute for Pharmacology, University of Ghent (L.M.A.B. Van B.), Ghent, Belgium; Department of Pharmacology and Toxicology, Cardiovascular Research Institute Maastricht, Universiteit Maastricht (H.A.J.S.-B.), Maastricht, The Netherlands; and Department of Internal Medicine and INSERM U337, Broussais Hospital (M.E.S.), Paris, France.

Correspondence to Prof Dr L.M.A.B. Van Bortel, Department of Clinical Pharmacology and Pharmacotherapy, Heymans Institute for Pharmacology, University of Ghent, De Pintelaan 185, B-9000 Ghent, Belgium. E-mail luc.vanbortel{at}rug.ac.be

Abstract

Abstract— Epidemiological studies in the past decade have stressed the importance of pulse pressure as an independent risk factor for cardiovascular morbidity and mortality. We briefly review the epidemiological evidence and discuss in more detail the pathophysiological basis for this observation and the therapeutic consequences. We focus on the vascular determinants of increased pulse pressure. Both longitudinal and cross-sectional components of the vascular system contribute to the shape of the arterial pressure wave and, thereby, to pulse pressure. The primary longitudinal component is the architecture of the arterial tree, which determines the major reflection sites for the pressure wave. The cross-sectional architecture of the vascular system consists of a geometric (diameter) and a structural (composition vessel wall) component. Both diameter and composition of the vessel wall vary greatly when going from central to more peripheral arteries. We review the implications for the functional properties of various arterial segments. Finally, we discuss the therapeutic consequences of targeting pulse pressure rather than mean blood pressure with various drug classes. Among the antihypertensive agents, nitrates, NO donors, and drugs that interfere with the renin-angiotensin-aldosterone system may offer useful tools to lower pulse pressure, in addition to mean blood pressure. Future developments may include non-antihypertensive agents that target collagen or other components of the arterial wall matrix. However, large-scale clinical trials will have to confirm the therapeutic value of these agents in the treatment of increased pulse pressure and arterial stiffness.


Key Words: antihypertensive agents • arterial stiffness • epidemiology • pulse pressure • blood pressure




This article has been cited by other articles:


Home page
Diabetes CareHome page
J.-C. Philips, M. Marchand, and A. J. Scheen
Squatting Amplifies Pulse Pressure Increase With Disease Duration in Patients With Type 1 Diabetes
Diabetes Care, February 1, 2008; 31(2): 322 - 324.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
S. M. Farasat, C. H. Morrell, A. Scuteri, C.-T. Ting, F. C.P. Yin, H. A. Spurgeon, C.-H. Chen, E. G. Lakatta, and S. S. Najjar
Pulse Pressure Is Inversely Related to Aortic Root Diameter Implications for the Pathogenesis of Systolic Hypertension
Hypertension, February 1, 2008; 51(2): 196 - 202.
[Abstract] [Full Text] [PDF]


Home page
ANGIOLOGYHome page
K. G. Moulakakis, D. P. Sokolis, D. N. Perrea, T. Dosios, I. Dontas, M. V. Poulakou, C. A. Dimitriou, G. Sandris, and P. E. Karayannacos
The Mechanical Performance and Histomorphological Structure of the Descending Aorta in Hyperthyroidism
Angiology, June 1, 2007; 58(3): 343 - 352.
[Abstract] [PDF]


Home page
Eur Heart JHome page
S. Laurent, J. Cockcroft, L. Van Bortel, P. Boutouyrie, C. Giannattasio, D. Hayoz, B. Pannier, C. Vlachopoulos, I. Wilkinson, H. Struijker-Boudier, et al.
Expert consensus document on arterial stiffness: methodological issues and clinical applications
Eur. Heart J., November 1, 2006; 27(21): 2588 - 2605.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
S. Taddei and L. Ghiadoni
Phosphodiesterase 5 Inhibition to Treat Essential Hypertension: Is This the Beginning of the Story?
Hypertension, October 1, 2006; 48(4): 546 - 548.
[Full Text] [PDF]


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
M. E. Safar
Systolic hypertension in elderly patients.
Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 2006; 10(3): 203 - 205.
[Abstract] [PDF]


Home page
HypertensionHome page
A.-I. Tropeano, P. Boutouyrie, B. Pannier, R. Joannides, E. Balkestein, S. Katsahian, B. Laloux, C. Thuillez, H. Struijker-Boudier, and S. Laurent
Brachial Pressure-Independent Reduction in Carotid Stiffness After Long-Term Angiotensin-Converting Enzyme Inhibition in Diabetic Hypertensives
Hypertension, July 1, 2006; 48(1): 80 - 86.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
Y. Li, J.-G. Wang, E. Dolan, P.-J. Gao, H.-F. Guo, T. Nawrot, A. V. Stanton, D.-L. Zhu, E. O'Brien, and J. A. Staessen
Ambulatory Arterial Stiffness Index Derived From 24-Hour Ambulatory Blood Pressure Monitoring
Hypertension, March 1, 2006; 47(3): 359 - 364.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
E. Dolan, L. Thijs, Y. Li, N. Atkins, P. McCormack, S. McClory, E. O'Brien, J. A. Staessen, and A. V. Stanton
Ambulatory Arterial Stiffness Index as a Predictor of Cardiovascular Mortality in the Dublin Outcome Study
Hypertension, March 1, 2006; 47(3): 365 - 370.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
S. J. Bielinski, A. I. Lynch, M. B. Miller, A. Weder, R. Cooper, A. Oberman, Y.-D. I. Chen, S. T. Turner, M. Fornage, M. Province, et al.
Genome-Wide Linkage Analysis for Loci Affecting Pulse Pressure: The Family Blood Pressure Program
Hypertension, December 1, 2005; 46(6): 1286 - 1293.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
A L Pauca, N D Kon, and M F O'Rourke
Benefit of glyceryl trinitrate on arterial stiffness is directly due to effects on peripheral arteries
Heart, November 1, 2005; 91(11): 1428 - 1432.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. Essalihi, H. H. Dao, L.-A. Gilbert, C. Bouvet, Y. Semerjian, M. D. McKee, and P. Moreau
Regression of Medial Elastocalcinosis in Rat Aorta: A New Vascular Function for Carbonic Anhydrase
Circulation, September 13, 2005; 112(11): 1628 - 1635.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
G. V. Nair, L. A. Chaput, E. Vittinghoff, D. M. Herrington, and for the Heart and Estrogen/Progestin Replacement S
Pulse Pressure and Cardiovascular Events in Postmenopausal Women With Coronary Heart Disease
Chest, May 1, 2005; 127(5): 1498 - 1506.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
G. de Simone, M. J. Roman, M. H. Alderman, M. Galderisi, O. de Divitiis, and R. B. Devereux
Is High Pulse Pressure a Marker of Preclinical Cardiovascular Disease?
Hypertension, April 1, 2005; 45(4): 575 - 579.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
G. S. Stokes, A. J Bune, N. Huon, and E. S. Barin
Long-Term Effectiveness of Extended-Release Nitrate for the Treatment of Systolic Hypertension
Hypertension, March 1, 2005; 45(3): 380 - 384.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
M. H. Tayebjee, H. S. Lim, R. J. MacFadyen, and G. Y.H. Lip
Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 and -2 in Type 2 Diabetes: Effect of 1 year's cardiovascular risk reduction therapy
Diabetes Care, August 1, 2004; 27(8): 2049 - 2051.
[Full Text] [PDF]


Home page
HypertensionHome page
I. B. Wilkinson, S. S. Franklin, and J. R. Cockcroft
Nitric Oxide and the Regulation of Large Artery Stiffness: From Physiology to Pharmacology
Hypertension, August 1, 2004; 44(2): 112 - 116.
[Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. E. Safar and P. Laurent
Pulse pressure and arterial stiffness in rats: comparison with humans
Am J Physiol Heart Circ Physiol, October 1, 2003; 285(4): H1363 - H1369.
[Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. K. Reddy, Y.-H. Li, T. T. Pham, L. N. Ochoa, M. T. Trevino, C. J. Hartley, L. H. Michael, M. L. Entman, and G. E. Taffet
Measurement of aortic input impedance in mice: effects of age on aortic stiffness
Am J Physiol Heart Circ Physiol, October 1, 2003; 285(4): H1464 - H1470.
[Abstract] [Full Text] [PDF]


Home page
Journals of Gerontology Series A: Biological Sciences and Medical SciencesHome page
J.-P. Michel, B. Grab, and J. J. Perrenoud
Commentary
J. Gerontol. A Biol. Sci. Med. Sci., July 1, 2003; 58(7): M665 - 666.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. de Divitiis, C. Pilla, M. Kattenhorn, A. Donald, M. Zadinello, S. Wallace, A. Redington, and J. Deanfield
Ambulatory blood pressure, left ventricular mass, and conduit artery function late after successful repair of coarctation of the aorta
J. Am. Coll. Cardiol., June 18, 2003; 41(12): 2259 - 2265.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. E. Safar, B. I. Levy, and H. Struijker-Boudier
Current Perspectives on Arterial Stiffness and Pulse Pressure in Hypertension and Cardiovascular Diseases
Circulation, June 10, 2003; 107(22): 2864 - 2869.
[Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
D. Goldsmith, R. MacGinley, A. Smith, and A. Covic
How important and how treatable is vascular stiffness as a cardiovascular risk factor in renal failure?
Nephrol. Dial. Transplant., June 1, 2002; 17(6): 965 - 969.
[Full Text] [PDF]


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
J. Ribstein, G. Du Cailar, and A. Zanchetti
Cardiac and renal damage in the elderly hypertensive
Journal of Renin-Angiotensin-Aldosterone System, March 1, 2002; 3(1_suppl): S16 - S24.
[PDF]


Home page
QJMHome page
S.E. Greenwald
Pulse pressure and arterial elasticity
QJM, February 1, 2002; 95(2): 107 - 112.
[Full Text] [PDF]